Merck & Co. Q419 Earnings: $MRK
-Revenue: $11.9B (est $11.98B)
-Adj EPS: $1.16 (est $1.15)
-Keytruda Revenue: $3.11B (est $3.30B)
-Sees 2020 Sales : $48.80B To $50.3B (est $49.43B)
-Sees 2020 Adj EPS: $5.62 To $5.77 (est $5.67)
-To Spinoff Women’s Health, Legacy Brands Including Biosimilar Products
-To Retain Dividend Of $2.44/Share Post Separation
-Targets 40%+ Operating Margin By 2024